Crescent Biopharma, Inc. (CBIO) — Cash Flow Quality Index
Crescent Biopharma, Inc. (CBIO) has a Cash Flow Quality Index of -0.59x as of June 2015. Operating cash flow of $-6.14 Million is below net income of $10.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Crescent Biopharma, Inc. (CBIO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Crescent Biopharma, Inc. Cash Flow Quality Index (2012–2012)
Historical Cash Flow Quality Index for Crescent Biopharma, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Crescent Biopharma, Inc. operating cash flow efficiency.
Annual Cash Flow Quality Index for Crescent Biopharma, Inc. (2012–2012)
Year-by-year earnings quality comparison for Crescent Biopharma, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | -2.86x | $-10.47 Million | $3.66 Million | — |